Monitor for precipitation or pH shifts before use in sensitive assays
BPC-157 and TB-500 promote angiogenesis and cell migration, processes linked to musculoskeletal tissue repair
Key safety findings include: No established LD50: Researchers haven't been able to determine a lethal dose in animal models, even at doses many times higher than therapeutic ranges No observed organ toxicity: Studies examining the effects of BPC-157 on liver, kidney, heart, and other organs haven't shown toxic effects No hormonal disruption: Unlike many compounds used for recovery and healing (such as growth hormone secretagogues or anabolic agents), BPC-157 doesn't appear to alter endocrine function No tumor promotion: Studies conducted to date haven't shown that BPC-157 promotes tumor growth or increases cancer risk, though this is an area that warrants continued monitoring Stable across administration routes: Both oral and injectable BPC-157 have shown comparable safety profiles Reported Side Effects Based on clinical observations and user reports, the side effects of BPC-157 are generally mild and self-limiting: Common Side Effects (Mild, Transient) Injection site reactions: Mild redness, minor swelling, or slight discomfort at the injection site
Some people are more likely to run low, including: Vegans and vegetarians People with digestive issues (like IBS or coeliac) Older adults Anyone on certain medications People recovering from illness We dont guess
1000166, 2016, [4] J
We assume that the exon 35 deletions with notation c.11381-?_11524+?del, detected via MLPA, and the c.11435_11524+30del variant, detected via NGS, 8 are likely the same variant
